A detailed history of Ra Capital Management, L.P. transactions in Insmed Inc stock. As of the latest transaction made, Ra Capital Management, L.P. holds 200,000 shares of INSM stock, worth $14 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares
200,000
Previous 200,000 -0.0%
Holding current value
$14 Million
Previous $13.4 Million 8.96%
% of portfolio
0.2%
Previous 0.2%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$22.0 - $69.71 $4.4 Million - $13.9 Million
200,000 New
200,000 $13.4 Million
Q3 2020

Nov 16, 2020

SELL
$26.0 - $34.5 $2.27 Million - $3.02 Million
-87,405 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$13.63 - $33.98 $1.19 Million - $2.97 Million
87,405 New
87,405 $1.4 Million
Q4 2017

Feb 14, 2018

SELL
$26.43 - $31.78 $19.1 Million - $23 Million
-722,714 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$11.61 - $31.21 $8.39 Million - $22.6 Million
722,714
722,714 $22.6 Million

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $9.48B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Ra Capital Management, L.P. Portfolio

Follow Ra Capital Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ra Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Ra Capital Management, L.P. with notifications on news.